Promotions & Moves
Related Searches:
Filter by:
646 - 660 of 1170 results
October 26, 2009
HollisterStier Contract Manufacturing and sister organization, Draxis Pharma, have appointed Steven Rowan as vice president of business development, Jubilant Organosys Contract Manufacturing North America.
Read More »
October 23, 2009
John L. Workman has been appointed executive vice president and chief financial officer, Omnicare, Inc., effective November 18th.
Read More »
October 22, 2009
Dr. Hui Cai has been appointed as vice president of business development, WuXi PharmaTech.
Read More »
October 19, 2009
Dr. Robert Garnick has joined Peregrine Pharmaceuticals as the head of regulatory affairs
Read More »
October 14, 2009
Susan Kramer, Dr. P.H., has been named vice president, Project and Alliance Management at XOMA
Read More »
October 13, 2009
Bruce J. Seeley has been named executive vice president, commercial at Seattle Genetics.
Read More »
October 12, 2009
David Wolton has been named vice president manufacturing at CMC Biologics
Read More »
October 9, 2009
Paul S. Changelian, Ph.D. and Peter L. Toogood, Ph.D. have been appointed to Lycera Corp.'s drug development team.
Read More »
October 6, 2009
Dr. Ganesh Iyer has been appointed president and chief executive officer, OctAlgos Therapeutics Inc., effective immediately.
Read More »
October 1, 2009
Troy W. McCall, Ph.D. has been promoted from chief operating officer to chief executive officer at Premier Research Group, effective immediately.
Read More »
October 1, 2009
Dr. John Nash has been named senior director of ADME/PK for BioFocus.
Read More »
September 30, 2009
Will Downie has been appointed group president, Sterile Technologies and senior vice president of Global Sales and Marketing, Catalent Pharma Solutions, effective October 12, 2009.
Read More »
September 18, 2009
Penn Pharma has appointed Karl Fry as director of quality. Mr. Fry joins the company from a quality management role at sterile pharmaceutical manufacturer, Patheon in Swindon.
Read More »
September 16, 2009
Lisa Rojkjaer, M.D. has been appointed vice president and head of clinical development at MorphoSys.
Read More »
September 15, 2009
In conjunction with Lilly’s recent restructuring initiative, the company has named the leaders of its Development Center of Excellence (CoE) and its five business units: oncology, diabetes, established markets, emerging markets, and Elanco animal he
Read More »
646 - 660 of 1170 results
